Holding the keys to health? A scoping study of the population health impacts of automated vehicles.

Automated vehicles Autonomous vehicles Built environment Driverless cars Health equity Mobility Public health Road safety Scoping review Transportation planning

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
11 Sep 2019
Historique:
received: 14 05 2019
accepted: 30 08 2019
entrez: 13 9 2019
pubmed: 13 9 2019
medline: 19 12 2019
Statut: epublish

Résumé

Automated Vehicles (AVs) are central to the new mobility paradigm that promises to transform transportation systems and cities across the globe. To date, much of the research on AVs has focused on technological advancements with little emphasis on how this emerging technology will impact population-level health. This scoping study examines the potential health impacts of AVs based on the existing literature. Using Arksey and O'Malley's scoping protocol, we searched academic and 'grey' literature to anticipate the effects of AVs on human health. Our search captured 43 information sources that discussed a least one of the five thematic areas related to health. The bulk of the evidence is related to road safety (n = 37), followed by a relatively equal distribution between social equity (n = 24), environment (n = 22), lifestyle (n = 20), and built environment (n = 18) themes. There is general agreement that AVs will improve road safety overall, thus reducing injuries and fatalities from human errors in operating motorized vehicles. However, the relationships with air quality, physical activity, and stress, among other health factors may be more complex. The broader health implications of AVs will be dependent on how the technology is adopted in various transportation systems. Regulatory action will be a significant determinant of how AVs could affect health, as well as how AVs influence social and environmental determinants of health. To support researchers and practitioners considering the health implications of AVs, we provide a conceptual map of the direct and indirect linkages between AV use and health outcomes. It is important that stakeholders, including public health agencies work to ensure that population health outcomes and equitable distribution of health impacts are priority considerations as regulators develop their response to AVs. We recommend that public health and transportation officials actively monitor trends in AV introduction and adoption, regulators focus on protecting human health and safety in AV implementation, and researchers work to expand the body of evidence surrounding AVs and population health.

Sections du résumé

BACKGROUND BACKGROUND
Automated Vehicles (AVs) are central to the new mobility paradigm that promises to transform transportation systems and cities across the globe. To date, much of the research on AVs has focused on technological advancements with little emphasis on how this emerging technology will impact population-level health. This scoping study examines the potential health impacts of AVs based on the existing literature.
METHODS METHODS
Using Arksey and O'Malley's scoping protocol, we searched academic and 'grey' literature to anticipate the effects of AVs on human health.
RESULTS RESULTS
Our search captured 43 information sources that discussed a least one of the five thematic areas related to health. The bulk of the evidence is related to road safety (n = 37), followed by a relatively equal distribution between social equity (n = 24), environment (n = 22), lifestyle (n = 20), and built environment (n = 18) themes. There is general agreement that AVs will improve road safety overall, thus reducing injuries and fatalities from human errors in operating motorized vehicles. However, the relationships with air quality, physical activity, and stress, among other health factors may be more complex. The broader health implications of AVs will be dependent on how the technology is adopted in various transportation systems. Regulatory action will be a significant determinant of how AVs could affect health, as well as how AVs influence social and environmental determinants of health.
CONCLUSION CONCLUSIONS
To support researchers and practitioners considering the health implications of AVs, we provide a conceptual map of the direct and indirect linkages between AV use and health outcomes. It is important that stakeholders, including public health agencies work to ensure that population health outcomes and equitable distribution of health impacts are priority considerations as regulators develop their response to AVs. We recommend that public health and transportation officials actively monitor trends in AV introduction and adoption, regulators focus on protecting human health and safety in AV implementation, and researchers work to expand the body of evidence surrounding AVs and population health.

Identifiants

pubmed: 31510986
doi: 10.1186/s12889-019-7580-9
pii: 10.1186/s12889-019-7580-9
pmc: PMC6740025
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1258

Références

Int J Nurs Stud. 2009 Oct;46(10):1386-400
pubmed: 19328488
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Lancet. 2009 Dec 5;374(9705):1930-43
pubmed: 19942277
Am J Public Health. 2010 Apr;100(4):590-5
pubmed: 20167880
Am J Public Health. 2012 Aug;102(8):1508-15
pubmed: 22698013
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):485-95
pubmed: 23462925
Prev Med. 2015 Jul;76:103-14
pubmed: 25900805
J Trauma Acute Care Surg. 2015 Oct;79(4):678-82
pubmed: 26402545
PLoS One. 2016 Mar 01;11(3):e0149990
pubmed: 26930213
Lancet. 2016 May 28;387(10034):2207-17
pubmed: 27045735
Can J Public Health. 2016 Jun 09;107(Suppl 1):5344
pubmed: 27281520
Accid Anal Prev. 2016 Oct;95(Pt A):104-15
pubmed: 27423430
Aust N Z J Public Health. 2017 Feb;41(1):5-7
pubmed: 27774760
Am J Public Health. 2017 Apr;107(4):532-537
pubmed: 28207327
J Public Health Policy. 2017 May;38(2):167-184
pubmed: 28533527
Br Med Bull. 2018 Mar 1;125(1):67-77
pubmed: 29309529
Inj Prev. 2019 Apr;25(2):76-79
pubmed: 29353244
Inj Epidemiol. 2018 Jun 4;5(1):24
pubmed: 29862417
J Aging Soc Policy. 2018 Aug 1;:1-11
pubmed: 30067473
J Air Waste Manag Assoc. 2018 Oct;68(10):1015-1024
pubmed: 30142033

Auteurs

Jennifer Dean (J)

School of Planning, University of Waterloo, 200 University Avenue West, Waterloo, ON, N2L 3G1, Canada. jennifer.dean@uwaterloo.ca.

Alexander J Wray (AJ)

Human Environments Analysis Lab, Department of Geography, Western University, London, ON, Canada.

Lucas Braun (L)

Department of Civil and Environmental Engineering, University of Waterloo, 200 University Ave, West, Waterloo, ON, N2L 3G1, Canada.

Jeffrey M Casello (JM)

School of Planning, University of Waterloo, 200 University Avenue West, Waterloo, ON, N2L 3G1, Canada.
Department of Civil and Environmental Engineering, University of Waterloo, 200 University Ave, West, Waterloo, ON, N2L 3G1, Canada.

Lindsay McCallum (L)

Toronto Public Health, 277 Victoria St., 7th Floor, Toronto, ON, M5B 1W2, Canada.

Stephanie Gower (S)

Toronto Public Health, 277 Victoria St., 7th Floor, Toronto, ON, M5B 1W2, Canada.
Dalla Lana School of Public Health, University of Toronto, 155 College St, Toronto, ON, M5T 3M7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH